Your Source for Venture Capital and Private Equity Financings

Massinvestor/VC News Daily

VC-funded Company:

Praxis Precision Medicines
101 Main St., #1210
Cambridge, MA 02142
Phone: 617-300-8460

Praxis Precision Medicines is a clinical-stage genetic neuroscience company developing breakthrough therapies for patients and families affected by complex and debilitating brain disorders, including psychiatric disorders, movement disorders and rare pediatric epilepsies. These disease areas share overlapping genetics and neurocircuit biology, as well as a profound need for new therapeutic options that target the underlying cause of the disease. Praxis is advancing a pipeline of breakthrough medicines with the potential to more precisely treat brain disorders.

Key Contact
Marcio Souza
Funding Events

05/04/20 $100,000,000 Blackstone Life Sciences
Eventide Asset Management
Novo Holdings
Vida Ventures
07/30/20 $110,000,000 Series C-1 Adage Capital Management
Avoro Capital Advisors
Blackstone Life Sciences
Cormorant Asset Management
Eventide Asset Management
Irving Investors
Novo Holdings
OCV Partners
Point72 Asset Management
Qatar Investment Authority
Surveyor Capital
Vida Ventures